Solarea bio announces licensing agreement with adm

Cambridge, mass., oct. 19, 2021 /prnewswire/ -- solarea bio, a biotech company based in cambridge, ma that is developing microbial-based solutions to aid human health, today announced it has signed a technology licensing agreement with global nutrition leader adm (nyse: adm).

ADM Ratings Summary

ADM Quant Ranking